DOW vs PRTA · P/E 74, rev $39.97B vs rev $1.0M
Dow Inc (DOW) versus Prothena Corporation plc (PRTA) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported PRTA revenue for 2026-06-30 was $1.0M. Net income was -$18.6M. Revenue was down 98.0% from 2026-03-31 to 2026-06-30. PRTA currently screens at market cap $460.2M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. PRTA currently screens at market cap $460.2M.
Not investment advice. Open the DOW and PRTA stock pages for the full models.
Not investment advice.